Article
ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
1 Jan 2021
Abstract excerpt
Hypoxia and angiogenesis play key roles in the pathogenesis of esophageal squamous cell carcinoma (ESCC), but regulators linking these two pathways to drive tumor progression remain elusive. Here we provide evidence of ADAM9's novel function in ESCC progression. Increasing expression of ADAM9 was correlated with poor clinical outcomes in ESCC patients. Suppression of ADAM9 function diminished ESCC cell migration...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
